의료기기 바이러스 불활성화 시험 시장 : 바이러스 유형별, 시험 방법별, 용도별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Medical Device Viral Inactivation Testing market size was valued at US$ 210.7 Million in 2025, expanding at a CAGR of 18.1% from 2026 to 2033.

Medical device viral inactivation testing is an important validation step that is performed on medical devices that come into contact with bodily fluids and tissue in order to assess whether the medical device is able to inactivate any viruses. If the medical device can effectively prove viral inactivation, there is increased assurance that patient infections will not occur due to the use of the device. It is an important factor to regulatory and manufacturing bodies that need to ensure that their products have effective infection control measures. The process ensures that viral load within the patient environment is lowered to a safe level. This testing strengthens infection control, regulatory compliance, and confidence in medical device safety.

Medical Device Viral Inactivation Testing Market- Market Dynamics

Expansion Of Complex And Minimally Invasive Medical Devices To Drive Market Demand

The expansion of complex and minimally invasive medical devices is expected to drive the Medical Device Viral Inactivation Testing market forward. This helps in the prevention of any kind of infections or contamination in such devices, especially by dangerous viruses. For example, in January 2026, according to the U.S. International Trade Administration (Trade Gov), the revenue of the medical technology industry in the UK stands at around $35,800 million (USD), employing more than 138,000 employees, and there are more than 4,000 medical technology firms working in the UK, most of which are SMEs (over 85%). Moreover, the number of medical technology companies has grown by more than 200% in the past ten years.

The National Health Service (NHS) contributes to 85% of the health care in the UK and spends an average of $6,600 million (USD) annually on clinical products that comprise medical technology. The spending of the NHS on medical technology is mostly related to implants and prosthetics; surgical, laboratory, IV, cardiovascular, and anesthesia equipment; radiology; and patient monitoring technologies. This trend is expected to strengthen demand for viral inactivation testing across advanced medical devices.

Medical Device Viral Inactivation Testing Market- Segmentation Analysis:

The Global Medical Device Viral Inactivation Testing market is segmented on the basis of Virus Type, Testing Method, Application, and Region.

Among the given virus types, enveloped viruses account for a prominent share of these viruses as model viruses used in viral inactivation validation studies and are susceptible to common antiviral drugs. It becomes easier to establish the safety of viruses in medical device manufacturing and sterilization processes. In July 2025, Eurofins BioPharma Product Testing Italy offered more viral clearance services in their Milan facility because of viral inactivation tests and viral removal tests on the biologics and medical devices in the medical device industry. This trend is expected to strengthen demand for enveloped virus testing in viral safety validation.

In the Medical Device Viral Inactivation Testing market, the biocompatibility testing segment represents a key testing method segment, as it provides for the safety and biological safety characteristics of a medical device prior to its launch into the market or any clinical trials and is also useful for manufacturing companies in meeting the requirements of regulatory authorities. In July 2025, NAMSA published a new report on biological testing methods for medical devices, emphasizing the biocompatibility testing in accordance with ISO 10993. The report stresses the importance of the risk-based biological evaluation of medical devices that includes chemical characterization and biological testing of the medical device depending on its application and contact. These activities support manufacturers in identifying biological risks and establishing appropriate testing strategies for regulatory submissions.

Medical Device Viral Inactivation Testing Market- Geographical Insights

North America maintains a key position in the global Medical Device Viral Inactivation Testing market, which is explained by the presence of high-quality guidelines and regulatory standards in the region. For instance, in February 2026, according to the U.S. Food and Drug Administration (Gov), the market is made up of 3 major types of devices. These include class I, class II, and class III. Class I to class III show a gradual increase in the regulatory control of devices. Most Class I devices are placed under the exempt category in regard to the need for 510 (k) premarket notification. Most class II devices need 510(k) clearance, while most class III devices require PMA. In addition, the FDA has 7 major requirements for the medical devices available in the United States.

These include establishment registration, device listing, 510(k) or PMA, Investigational Device Exemption (IDE), Quality Management System Regulation (QMSR), labeling, and Medical Device Reporting (MDR). There are 12 FDA-accredited third-party reviewers that cover 670 devices altogether. The FDA has an obligation to give its determination in 30 days after a recommendation by the accredited persons. This regulatory rigor strengthens North America's position as a key market for viral inactivation testing.

Medical Device Viral Inactivation Testing Market- Competitive Landscape:

The global Medical Device Viral Inactivation Testing market, which is globally present, has a competitive landscape that is quite diversified and includes both testing service providers and contract laboratories. Some of the major players that are part of the market and provide not just solutions but also testing facilities and also cater to the safety aspects of the medical device sector include Charles River, Perfectus Biomed (NAMSA), Eurofins Scientific, Nelson Labs, and Texcell. The market has the potential to innovate further, considering the increasing biosafety standards and advanced testing capability, among other factors. In January 2026, Charles River Laboratories announced that it intends to purchase the balance approximate 79% equity interest in PathoQuest SAS for approximately USD 60 million, enhancing its advanced next-generation sequencing technology for biopharmaceutical quality control and biosafety testing. The market is poised for continued innovation, driven by expanding biosafety requirements and advanced testing capabilities.

Recent Developments:

In March 2025, Nelson Labs introduced the Rapid Sterility Testing process, applying rapid microbiological techniques to shorten the time required to conduct product sterility tests to just 6 days, from the usual 14-day incubation period, in the medical device and pharmaceutical industries.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MEDICAL DEVICE VIRAL INACTIVATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Charles River Laboratories International, Inc.
• Perfectus Biomed Group
• Eurofins Scientific
• Nelson Laboratories
• Texcell
• Intertek Group plc
• LabCorp
• Syensqo
• SGS SA
• Pacific BioLabs
• Creative Biogene
• ProPharma Group
• Cormica Ltd. (Wickham Laboratories Ltd.)
• CTI
• WuXi AppTec
• Q Laboratories
• BioReliance (MilliporeSigma)
• ViruSure GmbH
• Others

GLOBAL MEDICAL DEVICE VIRAL INACTIVATION TESTING MARKET, BY VIRUS TYPE- MARKET ANALYSIS, 2020 - 2033

• Non-enveloped Viruses
• Enveloped Viruses

GLOBAL MEDICAL DEVICE VIRAL INACTIVATION TESTING MARKET, BY TESTING METHOD- MARKET ANALYSIS, 2020 - 2033

• Chemical Composition Analysis
• Microbiological & Reusability Validation
• Biocompatibility Testing

GLOBAL MEDICAL DEVICE VIRAL INACTIVATION TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

• Vascular Medical Equipment
• In Vitro Diagnostic Equipment
• Active Medical Equipment
• Ophthalmic Medical Equipment
• Active Implant Medical Devices
• Others

GLOBAL MEDICAL DEVICE VIRAL INACTIVATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. Medical Device Viral Inactivation Testing Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
• 2.2. Competitive Insights

3. Medical Device Viral Inactivation Testing Key Market Trends

• 3.1. Medical Device Viral Inactivation Testing Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Medical Device Viral Inactivation Testing Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Medical Device Viral Inactivation Testing Market Opportunities
• 3.4. Medical Device Viral Inactivation Testing Market Future Trends

4. Medical Device Viral Inactivation Testing Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Medical Device Viral Inactivation Testing Market : Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Medical Device Viral Inactivation Testing Market Landscape

• 6.1. Medical Device Viral Inactivation Testing Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Medical Device Viral Inactivation Testing Market - By Virus Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Virus Type, 2025 & 2033 (%)
  • 7.1.2. Non-enveloped Viruses
  • 7.1.3. Enveloped Viruses

8. Medical Device Viral Inactivation Testing Market - By Testing Method

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Testing Method, 2025 & 2033 (%)
  • 8.1.2. Chemical Composition Analysis
  • 8.1.3. Microbiological & Reusability Validation
  • 8.1.4. Biocompatibility Testing

9. Medical Device Viral Inactivation Testing Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
  • 9.1.2. Vascular Medical Equipment
  • 9.1.3. In Vitro Diagnostic Equipment
  • 9.1.4. Active Medical Equipment
  • 9.1.5. Ophthalmic Medical Equipment
  • 9.1.6. Active Implant Medical Devices
  • 9.1.7. Others

10. Medical Device Viral Inactivation Testing Market - By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Medical Device Viral Inactivation Testing Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Medical Device Viral Inactivation Testing Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.8. UK
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.8.3. UK Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.8.4. UK Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.8.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.9. France
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.9.3. France Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.9.4. France Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.9.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.10. Italy
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.10.3. Italy Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.10.4. Italy Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.10.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.11. Spain
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.11.3. Spain Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.11.4. Spain Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.11.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.12. The Netherlands
    • 10.3.12.1. Overview
    • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.12.3. The Netherlands Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.12.4. The Netherlands Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Overview
    • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.13.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.14. Russia
    • 10.3.14.1. Overview
    • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.14.3. Russia Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.14.4. Russia Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.14.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.15. Poland
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.15.3. Poland Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.15.4. Poland Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.15.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.16. Denmark
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.16.3. Denmark Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.16.4. Denmark Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.16.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3.17. Rest of Europe
    • 10.3.17.1. Overview
    • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Medical Device Viral Inactivation Testing Key Manufacturers in Asia Pacific
  • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.4.4. APAC Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
  • 10.4.5. APAC Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
  • 10.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.7. China
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.7.3. China Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.7.4. China Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.7.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.8. India
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.8.3. India Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.8.4. India Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.8.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.12. Indonesia
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.12.3. Indonesia Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.12.4. Indonesia Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.13. Thailand
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.13.3. Thailand Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.13.4. Thailand Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.13.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.15. Taiwan
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.15.3. Taiwan Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.15.4. Taiwan Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.15.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.16. Vietnam
    • 10.4.16.1. Overview
    • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.16.3. Vietnam Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.16.4. Vietnam Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.16.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4.17. Rest of APAC
    • 10.4.17.1. Overview
    • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.4.17.3. Rest of APAC Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.17.4. Rest of APAC Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.17.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
• 10.5. Latin America (LATAM)
  • 10.5.1. Overview
  • 10.5.2. Medical Device Viral Inactivation Testing Key Manufacturers in Latin America
  • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.5.4. LATAM Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
  • 10.5.5. LATAM Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
  • 10.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
• 10.6. Middle East and Africa (MEA)
  • 10.6.1. Overview
  • 10.6.2. Medical Device Viral Inactivation Testing Key Manufacturers in Middle East and Africa
  • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 10.6.4. MEA Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
  • 10.6.5. MEA Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
  • 10.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6.8. UAE
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.8.3. UAE Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.6.8.4. UAE Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.6.8.5. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6.13. Iran
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.13.3. Iran Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.6.13.4. Iran Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.6.13.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6.14. Qatar
    • 10.6.14.1. Overview
    • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.14.3. Qatar Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.6.14.4. Qatar Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.6.14.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6.15. Rest of MEA
    • 10.6.15.1. Overview
    • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 10.6.15.3. Rest of MEA Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.6.15.4. Rest of MEA Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.6.15.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Medical Device Viral Inactivation Testing Industry

• 11.1. Competitive Benchmarking
  • 11.1.1. Competitive Dashboard
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1. Charles River Laboratories International, Inc.
  • 11.2.2. Perfectus Biomed Group
  • 11.2.3. Eurofins Scientific
  • 11.2.4. Nelson Laboratories
  • 11.2.5. Texcell
  • 11.2.6. Intertek Group plc
  • 11.2.7. LabCorp
  • 11.2.8. Syensqo
  • 11.2.9. SGS SA
  • 11.2.10. Pacific BioLabs
  • 11.2.11. Creative Biogene
  • 11.2.12. ProPharma Group
  • 11.2.13. Cormica Ltd. (Wickham Laboratories Ltd.)
  • 11.2.14. CTI
  • 11.2.15. WuXi AppTec
  • 11.2.16. Q Laboratories
  • 11.2.17. BioReliance (MilliporeSigma)
  • 11.2.18. ViruSure GmbH
  • 11.2.19. Others

12. 360 Degree AnalystView

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us